Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South
Carolina. The investigators will assess 4 efficacious approaches to controlling
treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension
Specialist, Renin Treatment-Guided Therapeutics, and combination of Hypertension Specialist
and Renin Treatment-Guided Therapeutics. Patients with TRH are evaluated with the BpTRU
device for an accurate and representative blood pressure measure on two occasions before
entry into the study. Qualitative data from focus group discussions with practice staff, and
patient surveys and interviews will provide contextual data to help explain why some
interventions are more acceptable and successful than others.
Phase:
N/A
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
University of South Carolina
Treatments:
Coal Tar Mineralocorticoid Receptor Antagonists Spironolactone